Putative immunogenicity expression profiling using human pluripotent stem cells and derivatives

Stem Cells Translational Medicine

Volumn 4, Issue 2, 2015, Pages 136-145

  Awe, Jason P ^a   Gschweng, Eric H ^b   Vega Crespo, Cagustin ^a   Voutila, Jon ^a   Williamson, Mary H ^a   Truong, Brian ^a   Kohn, Donald B ^a,b   Kasahara, Noriyuki ^a   Byrne, James A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

HORMAD1; Human embryonic stem cell; Human induced pluripotent stem cell; Immunogenicity; Peripheral blood mononuclear cells; ZG16

Indexed keywords

GAMMA INTERFERON; LECTIN; MEMBRANE PROTEIN; ZG-16 PROTEIN, MOUSE; ZG16 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYOID BODY; EMBRYONIC STEM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOCYTOCHEMISTRY; IMMUNOGENICITY; MALE; MOUSE; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TERATOMA; WESTERN BLOTTING; ANIMAL; CELL LINE; CYTOLOGY; GENE EXPRESSION REGULATION; IMMUNOLOGY; SPECIES DIFFERENCE;

ANIMALS; CELL LINE; EMBRYONIC STEM CELLS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; LECTINS; MEMBRANE PROTEINS; MICE; PLURIPOTENT STEM CELLS; SPECIES SPECIFICITY;

EID: 84921772741     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2014-0117     Document Type: Article

References (33)

1. Byrne JA. Generation of isogenic pluripotent stemcells.Hum Mol Genet 2008;17(R1):R37-R41.
2. Chin MH, PellegriniM, Plath K et al. Molecular analyses of human induced pluripotent stem cells and embryonic stem cells. Cell Stem Cell 2010;7:263-269.
3. Bilic J, Izpisua Belmonte JC. Concise review: Induced pluripotent stem cells versus embryonic stem cells: Close enough or yet too far apart? STEM CELLS 2012;30:33-41.
4. Soldner F, Hockemeyer D, Beard C et al. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 2009;136:964-977.
5. Wang T,WuH, Li Y et al. Subtelomeric hotspots of aberrant 5-hydroxymethylcytosinemediated epigenetic modifications during reprogramming to pluripotency. Nat Cell Biol 2013;15:700-711.
6. Doi A, Park IH, Wen B et al. Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet 2009;41:1350-1353.
7. Kim K, Zhao R, Doi A et al. Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells. Nat Biotechnol 2011;29:1117-1119.
8. Lister R, PelizzolaM, Kida YS et al. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 2011;471:68-73.
9. Marchetto MC, Yeo GW, Kainohana O et al. Transcriptional signature and memory retention of human-induced pluripotent stem cells. PLoS One 2009;4:e7076.
10. Stadtfeld M, Apostolou E, Akutsu H et al. Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature 2010;465:175-181.
11. Mayshar Y, Ben-David U, Lavon N et al. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell 2010;7:521-531.
12. Hu BY, Weick JP, Yu J et al. Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci USA 2010; 107:4335-4340.
13. Zhao T, Zhang ZN, Rong Z et al. Immunogenicity of induced pluripotent stem cells. Nature 2011;474:212-215.
14. Araki R, UdaM,Hoki Y et al. Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells. Nature 2013;494:100-104.
15. Guha P,MorganJW,Mostoslavsky G et al. Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells. Cell Stem Cell 2013;12:407-412.
16. Maynard KM, Arvindam U, CrossMet al. Potentially immunogenic proteins expressed similarly in human embryonic stem cells and induced pluripotent stem cells. Exp Biol Med (Maywood) 2014;239:484-488.
17. Awe JP, Lee PC, Ramathal C et al. Generation and characterization of transgene-free human induced pluripotent stem cells and conversion to putative clinical-grade status. Stem Cell Res Ther 2013;4:87.
18. Karumbayaram S, Lee P, Azghadi SF et al. From skin biopsy to neurons through a pluripotent intermediate under Good Manufacturing Practice protocols. STEM CELLS TRANSLATIONAL MEDICINE 2012;1:36-43.
19. Sommer CA, Stadtfeld M, Murphy GJ et al. Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. STEM CELLS 2009;27:543-549.
20. Somers A, Jean JC, Sommer CA et al. Generation of transgene-free lung disease-specific human induced pluripotent stem cells using a single excisable lentiviral stem cell cassette. STEM CELLS 2010;28:1728-1740.
21. Tan JY, Sriram G, Rufaihah AJ et al. Efficient derivation of lateral plate and paraxial mesoderm subtypes from human embryonic stem cells through GSKi-mediated differentiation. Stem Cells Dev 2013;22:1893-1906.
22. Lian X, Hsiao C, WilsonGet al. Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc Natl Acad Sci USA 2012;109:E1848-E1857.
23. Lian X, Zhang J, Azarin SM et al. Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/betacatenin signaling under fully defined conditions. Nat Protoc 2013;8:162-175.
24. Izrael M, Zhang P, Kaufman R et al. Human oligodendrocytes derived from embryonic stem cells: Effect of noggin on phenotypic differentiation in vitro and on myelination in vivo. Mol Cell Neurosci 2007;34:310-323.
25. Bauwens CL, Peerani R, Niebruegge S et al. Control of human embryonic stem cell colony and aggregate size heterogeneity influences differentiation trajectories. STEM CELLS 2008;26:2300-2310.
26. Song Z, Cai J, Liu Y et al. Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells. Cell Res 2009; 19:1233-1242.
27. Kurosawa H. Methods for inducing embryoid body formation: In vitro differentiation system of embryonic stem cells. J Biosci Bioeng 2007;103:389-398.
28. Heins N, Englund MC, Sjöblom C et al. Derivation, characterization, and differentiation of human embryonic stem cells. STEM CELLS 2004;22:367-376.
29. Hwang YS, Chung BG, Ortmann D et al. Microwell-mediated control of embryoid body size regulates embryonic stem cell fate via differential expression of WNT5a and WNT11. Proc Natl Acad Sci USA 2009;106: 16978-16983.
30. Zhang P, Li J, Tan Z et al. Short-term BMP- 4 treatment initiates mesoderm induction in human embryonic stem cells. Blood 2008;111: 1933-1941.
31. Yao S, Chen S, Clark J et al. Long-term selfrenewal and directed differentiation of human embryonic stem cells in chemically defined conditions. Proc Natl Acad Sci USA 2006;103: 6907-6912.
32. Boyd AS, Higashi Y, Wood KJ. Transplanting stem cells: Potential targets for immune attack. Modulating the immune response against embryonic stem cell transplantation. Adv Drug Deliv Rev 2005;57:1944-1969.
33. Kruisbeek AM, Shevach E, Thornton AM. Proliferative assays for T cell function. Curr Protoc Immunol 2004;Chapter 3:Unit 3.12.